Table 4.
Compound* | IC50 (nM) |
mg/L | Efflux ratio in Caco2 permeability assay | Ref | ||
---|---|---|---|---|---|---|
CDK9 | CDK2 | Cytotoxicityᶧ | Aqueous solubility | |||
19 | 5 | >20000 | 160 | ND | ND | 57 |
20 | 5 | 16200 | 157 | ND | ND | 57 |
21 | 2 | 2450 | NT | ND | ND | 58 |
22 | 3 | 3590 | 55 | ND | ND | 58 |
23 | 3 | 87 | 25 | ND | ND | 59 |
24 | 4 | 71 | 33 | ND | ND | 59 |
25 | 4 | 69 | 77 | ND | ND | 59 |
26 | 13 | 790 | 370 | 155 | 5.6 | 60 |
27 | 17 | 2300 | 309 | 1.2 | 1.1 | 60 |
28 | 4 | 400 | 142 | 2.2 | 1.6 | 60 |
29 | 15 | 1300 | 682 | 97 | ND | 60 |
30 | 4 | 400 | 140 | 2.2 | 1.6 | 60 |
31 | 20 | 20000 | 1050 | ND | ND | 61 |
32 | 13 | 410 | 3000 | ND | ND | 61 |
CDK: cyclin-dependent kinase; IC50: half maximal inhibitory concentration; ND: not determined. *From corresponding structures in Figure 3. ᶧAverage of eight cell lines.